Platinum complexes having benzyl-based diphosphine ligands for the catalysis of the alkoxycarbonylation of ethylenically unsaturated compounds.

Use of transition metal complexes of the formula (I) in organic light-emitting diodes ##STR00001## where: M.sup.1 is a metal atom; carbene is a carbene ligand; L is a monoanionic or dianionic ligand; K is an uncharged monodentate or bidentate ligand selected from the group consisting of phosphines; CO; pyridines; nitriles and conjugated dienes which form a π complex with M.sup.1; n is the number of carbene ligands and is at least 1; m is the number of ligands L, where m can be 0 or ≥1; o is the number of ligands K, where o can be 0 or ≥1; where the sum n+m+o is dependent on the oxidation state and coordination number of the metal atom and on the denticity of the ligands carbene, L and K and also on the charge on the ligands carbene and L, with the proviso that n is at least 1, and also
an OLED comprising these transition metal complexes, a light-emitting layer comprising these transition metal complexes, OLEDs comprising this light-emitting layer, devices comprising an OLED according to the present invention, and specific transition metal complexes comprising atb least two carbene ligands.

The present application discloses a 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, an intermediate, a preparation method and uses thereof. The compound of phosphine ligand is a compound having a structure represented by formula I or formula II, or an enantiomer, a raceme, or diastereomer thereof. The phosphine ligand can be prepared via a preparation scheme in which the cheap and easily available 6,6′-dihydroxyl-3,3,3′,3′-tetramethyl-1,1′-spirobiindane is used as a raw material and the compound represented by formula III serves as the key intermediate. The new phosphine ligand developed by the present application can be used in catalytic organic reaction, in particular as a chiral phosphine ligand that is widely used in many asymmetric catalytic reactions including asymmetric hydrogenation and asymmetric allyl alkylation, and thus it has economic practicability and industrial application prospect. ##STR00001##

The present invention is drawn to artificial metalloenzymes for use in cyclopropanation reactions, amination and C—H insertion.

The invention describes single-site metal catalysts such as Pt single-site centers on powdered oxide supports with a 1,10-phenanthroline-5,6-dione (PDO) or bis-pyrimidyltetrazine (BMTZ) ligand on powdered MgO, Al.sub.2O.sub.3, or CeO.sub.2.

Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

The invention describes metal catalysts such as Pt single-site centers on metal oxide supports, e.g., powdered supports, such as MgO, Al.sub.2O.sub.3, CeO.sub.2 or mixtures thereof with di-nitrogen containing ligands.

Disclosed are a pincer-type ligand having a structurally rigid acridane structure and a metal complex consisting of the pincer-type ligand and a metal bound to each other, and exhibiting high reactivity and stability during a variety of bonding activation reactions. T-shaped complexes can be prepared from .sup.acriPNP(4,5-bis(diisopropylphosphino)-2,7,9,9-tetramethyl-9H-acridin-10-ide), which is a pincer-type PNP ligand having an acridane structure, and metal complexes, which can be structurally rigid and thus exhibit excellent reactivity and stability based on minimized structural change thereof, can be prepared by introducing an acridane structure into the backbone thereof. The PNP ligand is structurally stable and has novel chemical properties, as compared to conventional similar ligands, and thus can be utilized in a wide range of catalytic reactions and material chemistry.

The invention describes single-site metal catalysts such as Pt single-site centers with a 3,6-di-2-pyridyl-1,2,4,5-tetrazine (DPTZ) ligand on support such as a powdered MgO, Al.sub.2O.sub.3, CeO.sub.2 or mixtures thereof.

A composition containing the following components: (a) a hydrosilylation catalyst comprising a metal-ligand complex, and (b) an inhibitor of the catalyst, wherein the inhibitor differs from the ligand of the metal-ligand complex and is represented by formula (I):

X—CHR—CO—Y  (I),

wherein —X represents —NO.sub.2, —S(═O)R, or R.sup.c.sub.2R.sup.aC—CO—; Y represents 2-furyl, —S(═O)R, —CN, —NO.sub.2, or —CR.sup.b.sub.xR.sup.d.sub.3-x; R.sup.a and R.sup.b is independently selected from the group consisting of —O—R, —O—CO—R, —CO—O—R, 2-furyl, —S(═O)R, —CN, —NO.sub.2, —F, —Cl, and —Br; each of R is independently selected from the group consisting of —H, optionally fluorinated C.sub.1-C.sub.8-alkyl, —F, —Cl, and —Br; each of R.sup.c and each of R.sup.d is independently selected from the group consisting of —H, optionally fluorinated C.sub.1-C.sub.8-alkyl, —F, —Cl, and —Br; and x is 0 or 1.